Patents by Inventor Brian J. McLaughlin

Brian J. McLaughlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11937860
    Abstract: There is an implant, comprising a plate portion at a first end, and a stem portion at a second end extending away from an end of the plate portion. In one embodiment, the plate portion comprises a first lobe with a first screw hole; and a second lobe with a second screw hole, wherein the first lobe is adjacent to the second lobe. There is also method of inserting an implant, comprising preparing a patient's bones, performing an osteotomy on the patient's bones to form a first bone segment and a second bone segment, aligning the first bone segment and the second bone segment and inserting an implant into an intramedullary canal in the second bone segment.
    Type: Grant
    Filed: May 6, 2021
    Date of Patent: March 26, 2024
    Assignee: Paragon Advanced Technologies, Inc.
    Inventors: Selene G. Parekh, Gregory J. Kowalczyk, Brian R. McLaughlin
  • Publication number: 20240091020
    Abstract: There is disclosed a bone fixation device that can include a cage having an optional mesh portion. The bone fixation device can be configured to couple a leg portion to a foot portion of a user's body. In at least one embodiment, the device includes at least one cage having a plurality of struts forming cells. There can be an optional mesh portion having a pre-set porosity that can be either constant or variable in density. In at least one embodiment there can be a cage portion which is substantially spherical shaped. Alternatively, the device can be substantially egg shaped. In at least one embodiment there can be a central post hole for receiving a post. In another embodiment at least one plate or shaft can connect to the cage.
    Type: Application
    Filed: September 26, 2023
    Publication date: March 21, 2024
    Applicant: Paragon Advanced Technologies, Inc.
    Inventors: Gregory J. KOWALCZYK, Brian R. MCLAUGHLIN, Selene G. PAREKH, Luciano Bernardino BERTOLOTTI
  • Patent number: 11921844
    Abstract: A novel compiler is described. The compiler is able to view source code of the application in its entirety and can do so from the inside. Unlike other tools which examine the forensic data from an application crash after the fact, from the outside, the compiler of the present invention can provide novel data on function call stacks and function profiles during runtime. The application may be stopped immediately during runtime to prevent further or potential damage, but the forensic data that is collected is focused and can be used to show where vulnerabilities exists in the application and how they were exploited. Hashes are taken of function call stacks and used as unique identifiers or thumbprints which can be used to reduce the volume of forensic data that needs to be analyzed after an attack.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: March 5, 2024
    Assignee: Dellfer, Inc.
    Inventors: Brian H. Pescatore, James Blaisdell, Xonia Ivonne McLaughlin, Chetin Ersoy, Kenneth J. Wante
  • Publication number: 20090112154
    Abstract: The invention relates to a device and method for treating diabetic patients on insulin therapy. More specifically, the invention includes apparatus for infusing insulin into a patient in an amount determined by the patient's carbohydrate intake, blood glucose level, and the amount of insulin calculated to be present in the patient at the time the therapy is to be administered. In one embodiment, an insulin infusion device having an on-board processor obtains a patient's blood glucose value from a remote sensor and receives input from a user indicating their recent meal intake. The device may include an on-board food database for determining the carbohydrate content of the patient's recent meals and compare that with recent insulin deliveries into the patient to determine the insulin present in the patient prior to determining an appropriate insulin dosage.
    Type: Application
    Filed: October 30, 2008
    Publication date: April 30, 2009
    Applicant: Animas Corporation
    Inventors: Barbara A. Montgomery, Brian J. McLaughlin, Carl Brewer, Mark DeStefano, Marat Shkolnik
  • Publication number: 20090005729
    Abstract: Disclosed is a medical infusion device including a dedicated processing unit for detecting abnormal operation of the operation of the device. Specifically, a watchdog controller is employed as an independent monitor of the functioning of microprocessors used in the medical infusion device for controlling things such as RF communication, insulin infusion, and system integrity. Through the use of an independently-powered watchdog control system, the accuracy and reliability of the device is enhanced, resulting in greater assurance to the patient receiving periodic or continuous infusion of a drug.
    Type: Application
    Filed: June 27, 2007
    Publication date: January 1, 2009
    Applicant: Animas Corporation
    Inventors: Charles Hendrixson, Ian Maxwell Shipway, John Quinlan, Brian J. McLaughlin, Steven Getz
  • Patent number: 5321758
    Abstract: A power efficient hearing aid uses a programmable biasing technique to set the quiescent operating points of amplifiers used by the hearing aid to avoid excessive power usage by the hearing aid. The hearing aid also includes power supply circuitry which develops +1.25 volts and -1.25 volts relative to ground from a single +1.25 volt source. The hearing aid also conserves power by selectively disabling low frequency signal processing channels in the presence of relatively large amplitude ambient noise.
    Type: Grant
    Filed: October 8, 1993
    Date of Patent: June 14, 1994
    Assignee: Ensoniq Corporation
    Inventors: Albert J. Charpentier, Duane J. Loeper, Brian J. McLaughlin, Edouard A. Gauthier, David W. DiOrio
  • Patent number: 5111506
    Abstract: A power efficient hearing aid uses a programmable biasing technique to set the quiescent operating points of amplifiers used by the hearing aid to avoid excessive power usage by the hearing aid. The hearing aid also includes power supply circuitry which develops +1.25 volts and -1.25 volts relative to ground from a single +1.25 volt source. The hearing aid also conserves power by selectively disabling low frequency signal processing channels in the presence of relatively large amplitude ambient noise.
    Type: Grant
    Filed: March 2, 1989
    Date of Patent: May 5, 1992
    Assignee: Ensonig Corporation
    Inventors: Albert J. Charpentier, Duane J. Loeper, Brian J. McLaughlin, Edouard A. Gauthier, David W. DiOrio